Hirofumi Fujii
- Gastroenterology top 1%
-
- Medical Imaging Techniques and Applications 57
- Radiomics and Machine Learning in Medical Imaging 30
- Radiopharmaceutical Chemistry and Applications 22
-
- Gastric Cancer Management and Outcomes 26
- Lung Cancer Treatments and Mutations 18
- Oncology top 2%
- Cancer Treatment and Pharmacology 19
- Colorectal Cancer Treatments and Studies 18
- Otorhinolaryngology top 2%
-
- Breast Cancer Treatment Studies 16
Hirofumi Fujii
270 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 150
- Gastroenterology 397
- Radiology, Nuclear Medicine and Imaging 1.4k
- Pulmonary and Respiratory Medicine 1.9k
- Oncology 1.6k
- Otorhinolaryngology 198
Countries citing papers authored by Hirofumi Fujii
This map shows the geographic impact of Hirofumi Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Fujii more than expected).
Fields of papers citing papers by Hirofumi Fujii
This network shows the impact of papers produced by Hirofumi Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Fujii. The network helps show where Hirofumi Fujii may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirofumi Fujii, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 12 | |
| 5 | 2019 | 25 | |
| 6 | 2019 | 12 | |
| 7 | 2019 | 8 | |
| 8 | 2017 | 7 | |
| 9 | 2016 | 1 | |
| 10 | 2014 | 51 | |
| 11 | 2013 | 21 | |
| 12 | 2013 | 1 | |
| 13 | [A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients]. | 2005 | 5 |
| 14 | 2004 | 1 | |
| 15 | Hilar activity on the F-18 FDG whole-body PET studies | 1999 | 1 |
| 16 | A Registration Method with Inertial Sensor for Vision-based Augmented Reality | 1999 | 1 |
| 17 | Evaluation of Gigabit Ethernet with Java/HORB | 1998 | 2 |
| 18 | 1998 | 8 | |
| 19 | 1997 | 1 | |
| 20 | EXPERIMENTAL RESEARCH ON PROTOCOL OF INTER-VEHICLE COMMUNICATION FOR MULTIPLE VEHICLES | 1996 | 3 |
About Hirofumi Fujii
Hirofumi Fujii is a scholar working on Radiology, Nuclear Medicine and Imaging, Otorhinolaryngology and Oncology, having authored 282 papers that have together received 4.9k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (57 papers), Radiomics and Machine Learning in Medical Imaging (30 papers), Gastric Cancer Management and Outcomes (26 papers), Radiopharmaceutical Chemistry and Applications (22 papers), Cancer Treatment and Pharmacology (19 papers), Lung Cancer Treatments and Mutations (18 papers), Colorectal Cancer Treatments and Studies (18 papers) and Breast Cancer Treatment Studies (16 papers). The work is most often cited by research in Gastroenterology (397 citations), Radiology, Nuclear Medicine and Imaging (1.4k citations) and Pulmonary and Respiratory Medicine (1.9k citations). Hirofumi Fujii has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Atsushi Kubo, Yuko Kitagawa, Masaki Kitajima, Akira Shohtsu, Tetsuro Kubota, Tadaki Nakahara, Seiei Yasuda, John V. Frangioni, Wakoh Takahashi and Michiru Ide.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.